Intranasal in situ gelling liquid crystal for delivery of resveratrol ameliorates memory and neuroinflammation in Alzheimer's disease.

[1]  Anonymous,et al.  2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  U. Gupta,et al.  Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges , 2022, Expert opinion on drug delivery.

[3]  D. Siskind,et al.  Clozapine-Encapsulated Binary Mixed Micelles in Thermosensitive Sol–Gels for Intranasal Administration , 2022, Gels.

[4]  R. Pluta,et al.  Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer’s Disease Proteinopathy , 2021, International journal of molecular sciences.

[5]  M. Safo,et al.  Umuhengerin Neuroprotective Effects in Streptozotocin-Induced Alzheimer’s Disease Mouse Model via Targeting Nrf2 and NF-Kβ Signaling Cascades , 2021, Antioxidants.

[6]  M. Lim,et al.  Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease. , 2021, Accounts of chemical research.

[7]  M. Chorilli,et al.  Mucoadhesive Nanosystems for Nose-to-Brain Drug Delivery in the Treatment of Central Nervous System Diseases. , 2021, Current medicinal chemistry.

[8]  E. Bakir,et al.  Ion-Triggered In Situ Gelling Nanoemulgel as a Platform for Nose-to-Brain Delivery of Small Lipophilic Molecules , 2021, Pharmaceutics.

[9]  A. Andricopulo,et al.  2',6'-dihydroxy-4'-methoxy dihydrochalcone improves the cognitive impairment of Alzheimer's disease: a structure-activity relationship study. , 2021, Current topics in medicinal chemistry.

[10]  B. Sipos,et al.  Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery , 2021, Pharmaceuticals.

[11]  B. Forbes,et al.  Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels , 2021, International journal of nanomedicine.

[12]  P. van Dijck,et al.  p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis. , 2021, International journal of pharmaceutics.

[13]  A. L. Ruela,et al.  The liquid crystalline phase behaviour of a nasal formulation modifies the brain disposition of donepezil in rats in the treatment of Alzheimer's disease. , 2021, Colloids and surfaces. B, Biointerfaces.

[14]  M. Chorilli,et al.  Curcumin-loaded Polyethyleneimine and chitosan polymer-based Mucoadhesive liquid crystalline systems as a potential platform in the treatment of cervical Cancer , 2021 .

[15]  J. A. Oshiro-Júnior,et al.  In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis. , 2021, Medical mycology.

[16]  Shubhmita Bhatnagar,et al.  Advanced materials for drug delivery across mucosal barriers. , 2020, Acta biomaterialia.

[17]  Â. Fátima,et al.  Usnic acid enantiomers restore cognitive deficits and neurochemical alterations induced by Aβ1–42 in mice , 2020, Behavioural Brain Research.

[18]  B. Vigani,et al.  Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes , 2020, Pharmaceutics.

[19]  M. Chorilli,et al.  The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. , 2020, International journal of pharmaceutics.

[20]  Xianfeng Gao,et al.  Neuroprotective effect of resveratrol against radiation after surgically induced brain injury by reducing oxidative stress, inflammation, and apoptosis through NRf2/HO‐1/NF‐κB signaling pathway , 2020, Journal of biochemical and molecular toxicology.

[21]  M. Noroozian,et al.  Effect of memantine on expression of Bace1-as and Bace1 genes in STZ-induced Alzheimeric rats , 2020, Molecular Biology Reports.

[22]  K. Sugibayashi,et al.  Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[23]  N. E. El Sayed,et al.  Antia, a Natural Antioxidant Product, Attenuates Cognitive Dysfunction in Streptozotocin-Induced Mouse Model of Sporadic Alzheimer's Disease by Targeting the Amyloidogenic, Inflammatory, Autophagy, and Oxidative Stress Pathways , 2020, Oxidative medicine and cellular longevity.

[24]  Yuan-Lu Cui,et al.  Intranasal delivery of icariin via a nanogel-thermoresponsive hydrogel compound system to improve its antidepressant-like activity. , 2020, International journal of pharmaceutics.

[25]  M. Chorilli,et al.  Development and characterization of a novel liquid crystalline system containing sodium alginate for incorporation of trans-resveratrol intended for treatment of buccal candidiasis. , 2020, Die Pharmazie.

[26]  M. Morello,et al.  Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease , 2020, Experimental Gerontology.

[27]  P. K. Naik,et al.  Mucoadhesive formulations: innovations, merits, drawbacks, and future outlook , 2020, Pharmaceutical development and technology.

[28]  C. W. Nogueira,et al.  Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease , 2020, Molecular Biology Reports.

[29]  M. C. Bonferoni,et al.  Nose-to-Brain Delivery , 2020, Pharmaceutics.

[30]  C. Bladé,et al.  The effects of Vitis vinifera L. phenolic compounds on a blood-brain barrier culture model: Expression of leptin receptors and protection against cytokine-induced damage. , 2020, Journal of ethnopharmacology.

[31]  S. Gui,et al.  Facile Nose-to-brain delivery of Rotigotine-loaded Polymer Micelles Thermosensitive Hydrogels: in vitro Characterization and in vivo Behavior Study. , 2020, International journal of pharmaceutics.

[32]  A. Baby,et al.  Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation , 2019, Brazilian Journal of Pharmaceutical Sciences.

[33]  P. Destruel,et al.  Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time. , 2019, International journal of pharmaceutics.

[34]  N. Jha,et al.  Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease , 2019, Journal of neurochemistry.

[35]  Shuhong Han,et al.  Irisin Attenuates Neuroinflammation and Prevents the Memory and Cognitive Deterioration in Streptozotocin-Induced Diabetic Mice , 2019, Mediators of inflammation.

[36]  M. Gremião,et al.  In-Situ Gelling Liquid Crystal Mucoadhesive Vehicle for Curcumin Buccal Administration and Its Potential Application in the Treatment of Oral Candidiasis. , 2019, Journal of Biomedical Nanotechnology.

[37]  A. Tekade,et al.  Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain , 2019, Journal of liposome research.

[38]  B. Lamb,et al.  Inflammation as a central mechanism in Alzheimer's disease , 2018, Alzheimer's & dementia.

[39]  C. Sotomayor,et al.  Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis. , 2018, Molecular pharmaceutics.

[40]  M. Chorilli,et al.  Antimicrobial peptide-loaded liquid crystalline precursor bioadhesive system for the prevention of dental caries , 2018, International journal of nanomedicine.

[41]  N. Garti,et al.  Aggregation Behavior in One-Phase (Winsor IV) Microemulsion Systems , 2018 .

[42]  V. Cechinel-Filho,et al.  Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer’s disease: Effects against scopolamine and streptozotocin-induced cognitive dysfunctions , 2018, Steroids.

[43]  P. Mecocci,et al.  A Long Journey into Aging, Brain Aging, and Alzheimer’s Disease Following the Oxidative Stress Tracks , 2018, Journal of Alzheimer's disease : JAD.

[44]  S. Gui,et al.  Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion , 2018, RSC advances.

[45]  S. Mishra,et al.  Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats , 2018, Neurochemistry International.

[46]  M. Chorilli,et al.  An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation. , 2017, Materials science & engineering. C, Materials for biological applications.

[47]  G. Halliday,et al.  Pathology and hippocampal atrophy in Alzheimer's disease , 2017, The Lancet Neurology.

[48]  Sangyun Jeong,et al.  Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease , 2017, Molecules and cells.

[49]  A. Wąsik,et al.  The mechanism of neuroprotective action of natural compounds , 2017, Pharmacological reports : PR.

[50]  Lindsay M Lueptow,et al.  Novel Object Recognition Test for the Investigation of Learning and Memory in Mice. , 2017, Journal of visualized experiments : JoVE.

[51]  Neal J. Cohen,et al.  A Closer Look at the Hippocampus and Memory , 2017, Trends in Cognitive Sciences.

[52]  M. Hashemzaei,et al.  Neuro‐Protective Effects of Resveratrol on Carbon Monoxide‐Induced Toxicity in Male Rats , 2017, Phytotherapy research : PTR.

[53]  Ying Fan,et al.  Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer’s disease , 2017, Iranian journal of basic medical sciences.

[54]  N. Braidy,et al.  Resveratrol and Alzheimer’s Disease: Mechanistic Insights , 2017, Molecular Neurobiology.

[55]  A. Angelova,et al.  Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents. , 2017, Advances in colloid and interface science.

[56]  M. Hernandes,et al.  Intracerebroventricular Streptozotocin as a Model of Alzheimer’s Disease: Neurochemical and Behavioral Characterization in Mice , 2016, Neurotoxicity Research.

[57]  R. Schiffelers,et al.  In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System. , 2017, Molecular pharmaceutics.

[58]  Yu Zhang,et al.  Resveratrol ameliorates spatial learning memory impairment induced by Aβ1–42 in rats , 2017, Neuroscience.

[59]  A. Meneses,et al.  Role of GSK3 β and PP2A on Regulation of Tau Phosphorylation in Hippocampus and Memory Impairment in ICV-STZ Animal Model of Alzheimer’s Disease , 2017 .

[60]  R. He,et al.  Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells , 2017, Frontiers in neuroscience.

[61]  Alan B. Watts,et al.  Formulation and device design to increase nose to brain drug delivery , 2016 .

[62]  Chandra Shakar Reddy Nalagoni,et al.  Protective effect of resveratrol against neuronal damage through oxidative stress in cerebral hemisphere of aluminum and fluoride treated rats , 2016, Interdisciplinary toxicology.

[63]  N. K. Jain,et al.  Mucoadhesion: A promising approach in drug delivery system , 2016 .

[64]  M. Chorilli,et al.  Design and Characterization of a Novel p1025 Peptide-Loaded Liquid Crystalline System for the Treatment of Dental Caries , 2016, Molecules.

[65]  M. Chorilli,et al.  Peptide KSL-W-Loaded Mucoadhesive Liquid Crystalline Vehicle as an Alternative Treatment for Multispecies Oral Biofilm , 2015, Molecules.

[66]  M. Gremião,et al.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease , 2015, International journal of nanomedicine.

[67]  R. Schiffelers,et al.  An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  P. Kamat.  Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism , 2015, Neural regeneration research.

[69]  G. Pasinetti,et al.  Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. , 2015, Biochimica et biophysica acta.

[70]  Y. Yazır,et al.  Resveratrol exerts anti-inflammatory and neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress , 2015, Physiology & Behavior.

[71]  Ran Liu,et al.  Exploring the association between interleukin-1β and its interacting proteins in Alzheimer’s disease , 2015, Molecular medicine reports.

[72]  E. Watanabe,et al.  Mucoadhesive system formed by liquid crystals for buccal administration of poly(hexamethylene biguanide) hydrochloride. , 2014, Journal of pharmaceutical sciences.

[73]  J. Jia,et al.  Enhancement of &bgr;-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model , 2014, Neuroreport.

[74]  D. Stepensky,et al.  Quantitative analysis of drug delivery to the brain via nasal route. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[75]  Clive G. Wilson,et al.  Drug delivery across the nasal mucosa , 2014 .

[76]  Yueze Liu,et al.  Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK3β Pathway in Streptozotocin‐Induced Alzheimer Rat Model , 2014, Brain pathology.

[77]  K. Anoop,et al.  Smart polymers for the controlled delivery of drugs – a concise overview , 2014, Acta pharmaceutica Sinica. B.

[78]  Javed Ali,et al.  Insights into direct nose to brain delivery: current status and future perspective , 2014, Drug delivery.

[79]  S. Rai,et al.  Glial activation and post-synaptic neurotoxicity: The key events in Streptozotocin (ICV) induced memory impairment in rats , 2014, Pharmacology Biochemistry and Behavior.

[80]  M. Gremião,et al.  Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[81]  E. Tamaddonfard,et al.  Crocin Improved Learning and Memory Impairments in Streptozotocin-Induced Diabetic Rats , 2013, Iranian journal of basic medical sciences.

[82]  P. Djupesland.  Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review , 2012, Drug Delivery and Translational Research.

[83]  Raffaele Mezzenga,et al.  Physics of Self-Assembly of Lyotropic Liquid Crystals , 2012 .

[84]  B. Boyd,et al.  Stimuli-responsive lipid-based self-assembled systems , 2012 .

[85]  Ponisseril Somasundaran,et al.  Self-assembled supramolecular architectures : lyotropic liquid crystals , 2012 .

[86]  J. Chavis,et al.  Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. , 2012, Biochemical and biophysical research communications.

[87]  D. Mcclements.  Nanoemulsions versus microemulsions: terminology, differences, and similarities , 2012 .

[88]  M. Biavatti,et al.  The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: evidence for the involvement of adrenergic, dopaminergic and serotonergic systems. , 2012, European journal of pharmacology.

[89]  M. Antunes,et al.  The novel object recognition memory: neurobiology, test procedure, and its modifications , 2011, Cognitive Processing.

[90]  S. Karavana,et al.  Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base , 2011, Pharmaceutical development and technology.

[91]  S. Pinton,et al.  Sporadic dementia of Alzheimer's type induced by streptozotocin promotes anxiogenic behavior in mice , 2011, Behavioural Brain Research.

[92]  S. Neau,et al.  Rheological and mucoadhesive characterization of poly(vinylpyrrolidone) hydrogels designed for nasal mucosal drug delivery , 2011, Archives of pharmacal research.

[93]  Thierry F. Vandamme,et al.  Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences , 2011, Pharmaceutical Research.

[94]  H. Bohidar,et al.  Rheological properties of binary and ternary protein-polysaccharide co-hydrogels and comparative release kinetics of salbutamol sulphate from their matrices. , 2011, International journal of biological macromolecules.

[95]  T. Walle.  Bioavailability of resveratrol , 2011, Annals of the New York Academy of Sciences.

[96]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[97]  M. Barbi,et al.  Surfactant systems for nasal zidovudine delivery: structural, rheological and mucoadhesive properties , 2010, The Journal of pharmacy and pharmacology.

[98]  M. Biavatti,et al.  Evaluation of behavioral and pharmacological effects of Hedyosmum brasiliense and isolated sesquiterpene lactones in rodents. , 2010, Journal of ethnopharmacology.

[99]  O. Forlenza,et al.  Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment , 2009, Dementia and Geriatric Cognitive Disorders.

[100]  David S. Jones,et al.  Characterization of the Rheological, Mucoadhesive, and Drug Release Properties of Highly Structured Gel Platforms for Intravaginal Drug Delivery , 2009, Biomacromolecules.

[101]  Chi H. Lee,et al.  Thixotropic property in pharmaceutical formulations. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[102]  David S Jones,et al.  Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. , 2009, International journal of pharmaceutics.

[103]  David S. Jones,et al.  Mucoadhesive polymeric platforms for controlled drug delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[104]  P. Davies,et al.  Therapeutic potential of resveratrol in Alzheimer's disease , 2008, BMC Neuroscience.

[105]  M. O’Banion,et al.  The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective , 2008, Journal of Neuroinflammation.

[106]  Hong-Qi Yang,et al.  New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α‐secretase activity , 2007, The European journal of neuroscience.

[107]  R. Quirion,et al.  Neuroprotective Effects of Natural Products: Interaction with Intracellular Kinases, Amyloid Peptides and a Possible Role for Transthyretin , 2007, Neurochemical Research.

[108]  Martin Malmsten,et al.  Phase Transformations in Self‐Assembly Systems for Drug Delivery Applications , 2007 .

[109]  Tristan Richard,et al.  Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro , 2007 .

[110]  Rick A Bevins,et al.  Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory' , 2006, Nature Protocols.

[111]  Li Luo,et al.  [Effect of resveratrol on the cognitive ability of Alzheimeros mice]. , 2006, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[112]  Yung-Hyun Choi,et al.  Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. , 2006, International journal of molecular medicine.

[113]  Afsaneh Lavasanifar,et al.  Polymeric micelles for drug delivery , 2006, Expert opinion on drug delivery.

[114]  Andrew D. Steele,et al.  Increase in Activity During Calorie Restriction Requires Sirt1 , 2005, Science.

[115]  Peter Davies,et al.  Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.

[116]  J. Smart.  The basics and underlying mechanisms of mucoadhesion. , 2005, Advanced drug delivery reviews.

[117]  R. Hayward,et al.  Shear rheology of lyotropic liquid crystals: a case study. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[118]  Samantha A. Stewart.  The effects of benzodiazepines on cognition. , 2005, The Journal of clinical psychiatry.

[119]  T. Walle,et al.  HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.

[120]  Denis Vivien,et al.  Cytokines in neuroinflammation and Alzheimer's disease. , 2004, Current drug targets.

[121]  Wenhua Zheng,et al.  Neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C , 2004, British journal of pharmacology.

[122]  E. Seifritz,et al.  Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity , 2003, Gerontology.

[123]  Y. Surh,et al.  Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death ☆ , 2003 .

[124]  L. Illum.  Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[125]  L. Illum.  Nasal drug delivery: new developments and strategies. , 2002, Drug discovery today.

[126]  David S. Jones,et al.  Examination of the flow rheological and textural properties of polymer gels composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone): rheological and mathematical interpretation of textural parameters. , 2002, Journal of pharmaceutical sciences.

[127]  Martin Malmsten,et al.  Surfactants and Polymers in Drug Delivery , 2002 .

[128]  M. Malmsten.  Degradation of Surfactants and Polymers in Drug Delivery , 2002 .

[129]  A. Ludwig,et al.  The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin. , 2002, Journal of pharmaceutical sciences.

[130]  I. Izquierdo,et al.  Effects of Posttraining Treatments in the Posterior Cingulate Cortex on Short- and Long-Term Memory for Inhibitory Avoidance in Rats , 2002, Neurobiology of Learning and Memory.

[131]  G. Biessels,et al.  Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task , 2001, Behavioural Brain Research.

[132]  S. Young,et al.  Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate , 2001, The Journal of pharmacy and pharmacology.

[133]  K. Peh,et al.  Effect of carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels , 2000, AAPS PharmSciTech.

[134]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[135]  F. A. Andersen.  Final Report on the Safety Assessment of Oleth-2, -3, -4, -5, -6, -7, -8, -9, -10, -11, -12, -15, -16, -20, -23, -25, -30, -40, -44, and -501 , 1999 .

[136]  L. Nielsen,et al.  Bioadhesive drug delivery systems: I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate , 1998 .

[137]  I. Izquierdo,et al.  Mechanisms for memory types differ , 1998, Nature.

[138]  David S. Jones,et al.  Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers , 1997 .

[139]  David S. Jones,et al.  Texture profile analysis of bioadhesive polymeric semisolids: Mechanical characterization and investigation of interactions between formulation components , 1996 .

[140]  J. Israelachvili.  The science and applications of emulsions — an overview , 1994 .

[141]  J. Archer.  Tests for emotionality in rats and mice: a review. , 1973, Animal behaviour.

[142]  K. Nealy,et al.  Benzodiazepine use and cognitive decline in the elderly. , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[143]  Dimitrios G Fatouros,et al.  Smart materials: in situ gel-forming systems for nasal delivery. , 2016, Drug discovery today.

[144]  M. Kupczyk,et al.  Thixotropy of nasal medications—its role in clinical practice. , 2015, Pneumonologia i alergologia polska.

[145]  Allan S Hoffman,et al.  Stimuli-responsive polymers: biomedical applications and challenges for clinical translation. , 2013, Advanced drug delivery reviews.

[146]  Jacob N. Israelachvili,et al.  20 – Soft and Biological Structures , 2011 .

[147]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[148]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[149]  B. Ninham,et al.  Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers , 1976 .

[150]  W. C. Griffin.  Classification of surface-active agents by "HLB" , 1946 .